Human chorionic gonadotropin free β-subunit in the human seminal plasma: A new marker for spermatogenesis?

E. Caroppo, C. Niederberger, P. A. Iacovazzi, M. Correale, A. Palagiano, G. D'Amato

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the past 20 years, several factors were detected in the human seminal plasma and proposed as markers for spermatogenesis. Human chorionic gonadotropin (hCG) and its β-subunit were therefore investigated, and their seminal levels were found to be higher than those detected in the serum and to correlate with sperm parameters. Objective: We designed a retrospective study to determine the suitability of hCG free β-subunit concentration in the seminal plasma of fertile and infertile male patients as marker of spermatogenesis. Study design: A total of 79 infertile male patients were divided into four groups by their semen analysis results (group 1 [n = 8]: azoospermia; group 2 [n = 21]: severe oligozoospermia; group 3 [n = 40]: oligoasthenospermia (OAS); group 4 [n = 10]: asthenospermia) and 10 healthy volunteers of proven fertility were evaluated. Results: The hCG free β-subunit levels in the seminal plasma were found to be significantly higher (P <0.0001) in the control group in respect to those assayed in the infertile patients and showed a correlation with sperm count (r = 0.5) and total motile sperm density (r = 0.5). Twenty-five patients were on treatment with oral Mesterolone (100 mg daily) plus Tamoxifen (20 mg daily) for 3-6 months. Apart from a significant improvement (P <0.05) in sperm morphology, no significant changes in sperm count and motility were observed after the treatment in all the patients. In the seminal plasma of 10 patients who showed a significant increase in sperm count, hCG free β-subunit levels were found to be significantly higher compared to those detected in the remaining patients (P <0.01). In all patients, these levels remained unchanged after the treatment. Conclusions: The evidence regarding the positive correlation between hCG free β-subunit levels in the seminal plasma and sperm concentration is consistent with the previous results regarding hCG levels. A previous study demonstrated that testosterone levels in seminal plasma correlated with sperm concentrations; from the same evidence regarding hCG we hypothesize that seminal plasma testosterone and hCG levels are correlated. Thus, hCG may play a paracrine role in the intratesticular regulation of testosterone secretion.

Original languageEnglish
Pages (from-to)165-169
Number of pages5
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume106
Issue number2
DOIs
Publication statusPublished - Feb 10 2003

Fingerprint

Chorionic Gonadotropin
Spermatogenesis
Semen
Spermatozoa
Sperm Count
Testosterone
Mesterolone
Oligospermia
Azoospermia
Semen Analysis
Sperm Motility
Tamoxifen
Fertility
Healthy Volunteers
Therapeutics
Retrospective Studies
Control Groups
Serum

Keywords

  • hCG free β-subunit
  • Human seminal plasma
  • Male infertility
  • Mesterolone
  • Spermatogenesis
  • Tamoxifen

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Human chorionic gonadotropin free β-subunit in the human seminal plasma : A new marker for spermatogenesis? / Caroppo, E.; Niederberger, C.; Iacovazzi, P. A.; Correale, M.; Palagiano, A.; D'Amato, G.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 106, No. 2, 10.02.2003, p. 165-169.

Research output: Contribution to journalArticle

Caroppo, E. ; Niederberger, C. ; Iacovazzi, P. A. ; Correale, M. ; Palagiano, A. ; D'Amato, G. / Human chorionic gonadotropin free β-subunit in the human seminal plasma : A new marker for spermatogenesis?. In: European Journal of Obstetrics and Gynecology and Reproductive Biology. 2003 ; Vol. 106, No. 2. pp. 165-169.
@article{ac5c2453c9714ccc8b8b57cc2b01dafa,
title = "Human chorionic gonadotropin free β-subunit in the human seminal plasma: A new marker for spermatogenesis?",
abstract = "In the past 20 years, several factors were detected in the human seminal plasma and proposed as markers for spermatogenesis. Human chorionic gonadotropin (hCG) and its β-subunit were therefore investigated, and their seminal levels were found to be higher than those detected in the serum and to correlate with sperm parameters. Objective: We designed a retrospective study to determine the suitability of hCG free β-subunit concentration in the seminal plasma of fertile and infertile male patients as marker of spermatogenesis. Study design: A total of 79 infertile male patients were divided into four groups by their semen analysis results (group 1 [n = 8]: azoospermia; group 2 [n = 21]: severe oligozoospermia; group 3 [n = 40]: oligoasthenospermia (OAS); group 4 [n = 10]: asthenospermia) and 10 healthy volunteers of proven fertility were evaluated. Results: The hCG free β-subunit levels in the seminal plasma were found to be significantly higher (P <0.0001) in the control group in respect to those assayed in the infertile patients and showed a correlation with sperm count (r = 0.5) and total motile sperm density (r = 0.5). Twenty-five patients were on treatment with oral Mesterolone (100 mg daily) plus Tamoxifen (20 mg daily) for 3-6 months. Apart from a significant improvement (P <0.05) in sperm morphology, no significant changes in sperm count and motility were observed after the treatment in all the patients. In the seminal plasma of 10 patients who showed a significant increase in sperm count, hCG free β-subunit levels were found to be significantly higher compared to those detected in the remaining patients (P <0.01). In all patients, these levels remained unchanged after the treatment. Conclusions: The evidence regarding the positive correlation between hCG free β-subunit levels in the seminal plasma and sperm concentration is consistent with the previous results regarding hCG levels. A previous study demonstrated that testosterone levels in seminal plasma correlated with sperm concentrations; from the same evidence regarding hCG we hypothesize that seminal plasma testosterone and hCG levels are correlated. Thus, hCG may play a paracrine role in the intratesticular regulation of testosterone secretion.",
keywords = "hCG free β-subunit, Human seminal plasma, Male infertility, Mesterolone, Spermatogenesis, Tamoxifen",
author = "E. Caroppo and C. Niederberger and Iacovazzi, {P. A.} and M. Correale and A. Palagiano and G. D'Amato",
year = "2003",
month = "2",
day = "10",
doi = "10.1016/S0301-2115(02)00231-2",
language = "English",
volume = "106",
pages = "165--169",
journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Human chorionic gonadotropin free β-subunit in the human seminal plasma

T2 - A new marker for spermatogenesis?

AU - Caroppo, E.

AU - Niederberger, C.

AU - Iacovazzi, P. A.

AU - Correale, M.

AU - Palagiano, A.

AU - D'Amato, G.

PY - 2003/2/10

Y1 - 2003/2/10

N2 - In the past 20 years, several factors were detected in the human seminal plasma and proposed as markers for spermatogenesis. Human chorionic gonadotropin (hCG) and its β-subunit were therefore investigated, and their seminal levels were found to be higher than those detected in the serum and to correlate with sperm parameters. Objective: We designed a retrospective study to determine the suitability of hCG free β-subunit concentration in the seminal plasma of fertile and infertile male patients as marker of spermatogenesis. Study design: A total of 79 infertile male patients were divided into four groups by their semen analysis results (group 1 [n = 8]: azoospermia; group 2 [n = 21]: severe oligozoospermia; group 3 [n = 40]: oligoasthenospermia (OAS); group 4 [n = 10]: asthenospermia) and 10 healthy volunteers of proven fertility were evaluated. Results: The hCG free β-subunit levels in the seminal plasma were found to be significantly higher (P <0.0001) in the control group in respect to those assayed in the infertile patients and showed a correlation with sperm count (r = 0.5) and total motile sperm density (r = 0.5). Twenty-five patients were on treatment with oral Mesterolone (100 mg daily) plus Tamoxifen (20 mg daily) for 3-6 months. Apart from a significant improvement (P <0.05) in sperm morphology, no significant changes in sperm count and motility were observed after the treatment in all the patients. In the seminal plasma of 10 patients who showed a significant increase in sperm count, hCG free β-subunit levels were found to be significantly higher compared to those detected in the remaining patients (P <0.01). In all patients, these levels remained unchanged after the treatment. Conclusions: The evidence regarding the positive correlation between hCG free β-subunit levels in the seminal plasma and sperm concentration is consistent with the previous results regarding hCG levels. A previous study demonstrated that testosterone levels in seminal plasma correlated with sperm concentrations; from the same evidence regarding hCG we hypothesize that seminal plasma testosterone and hCG levels are correlated. Thus, hCG may play a paracrine role in the intratesticular regulation of testosterone secretion.

AB - In the past 20 years, several factors were detected in the human seminal plasma and proposed as markers for spermatogenesis. Human chorionic gonadotropin (hCG) and its β-subunit were therefore investigated, and their seminal levels were found to be higher than those detected in the serum and to correlate with sperm parameters. Objective: We designed a retrospective study to determine the suitability of hCG free β-subunit concentration in the seminal plasma of fertile and infertile male patients as marker of spermatogenesis. Study design: A total of 79 infertile male patients were divided into four groups by their semen analysis results (group 1 [n = 8]: azoospermia; group 2 [n = 21]: severe oligozoospermia; group 3 [n = 40]: oligoasthenospermia (OAS); group 4 [n = 10]: asthenospermia) and 10 healthy volunteers of proven fertility were evaluated. Results: The hCG free β-subunit levels in the seminal plasma were found to be significantly higher (P <0.0001) in the control group in respect to those assayed in the infertile patients and showed a correlation with sperm count (r = 0.5) and total motile sperm density (r = 0.5). Twenty-five patients were on treatment with oral Mesterolone (100 mg daily) plus Tamoxifen (20 mg daily) for 3-6 months. Apart from a significant improvement (P <0.05) in sperm morphology, no significant changes in sperm count and motility were observed after the treatment in all the patients. In the seminal plasma of 10 patients who showed a significant increase in sperm count, hCG free β-subunit levels were found to be significantly higher compared to those detected in the remaining patients (P <0.01). In all patients, these levels remained unchanged after the treatment. Conclusions: The evidence regarding the positive correlation between hCG free β-subunit levels in the seminal plasma and sperm concentration is consistent with the previous results regarding hCG levels. A previous study demonstrated that testosterone levels in seminal plasma correlated with sperm concentrations; from the same evidence regarding hCG we hypothesize that seminal plasma testosterone and hCG levels are correlated. Thus, hCG may play a paracrine role in the intratesticular regulation of testosterone secretion.

KW - hCG free β-subunit

KW - Human seminal plasma

KW - Male infertility

KW - Mesterolone

KW - Spermatogenesis

KW - Tamoxifen

UR - http://www.scopus.com/inward/record.url?scp=0037428942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037428942&partnerID=8YFLogxK

U2 - 10.1016/S0301-2115(02)00231-2

DO - 10.1016/S0301-2115(02)00231-2

M3 - Article

C2 - 12551786

AN - SCOPUS:0037428942

VL - 106

SP - 165

EP - 169

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

IS - 2

ER -